iData’s full report on the Global Interventional Cardiology Market includes in-depth information on the following segments: Coronary Atherectomy Devices Catheters Guidewires Introducer Sheaths Vascular Closure Balloon Inflation CEP Devices Overall, the global pandemic (COVID-19) resulted in a substantial decline in the global interventional cardiology market. The global interventional cardiology market, as most medical device markets,

Market trends for the global Left Atrial Appendage (LAA) Closure Device Market indicate growth over the forecast period and into 2027. Overall, the global LAA market had a valuation of approximately $697 million in 2020. Due to the global COVID-19 pandemic, the LAA market experienced a significant decrease in revenue between 2019 and 2020. Despite

2020 was an unusual year mainly because of the global COVID-19 pandemic, which caused a decrease in the Global Atherectomy Market from 2019 to 2020. While the value of the total atherectomy device market decreased in 2020, due primarily to COVID-19, iData forecasts that the market is expected to grow over the forecast period following

iData’s report on the global central venous catheter (CVC) market includes both acute and chronic CVC’s. In the past, the central venous catheter market suffered extreme consequences after the Joint Commission guidelines recommended that catheters should only be placed in the femoral vein if no other sites are available. This recommendation was due to the

Throughout iData’s MedSKU analysis, six companies and over 30 brands were analyzed within six market segments including IVUS consoles, IVUS catheters, OCT consoles, OCT catheters, FFR consoles, and FFR catheters. Despite many market segments included in the MedSKU analysis, this blog focuses and dives deep into three specific segments: Intravascular Ultrasound (IVUS) Catheters  Fractional Flow

Globally, the electrophysiology and cardiac ablation catheter markets are growing at a steady pace. Individually, the electrophysiology (EP) catheter market value is increasing into 2025, and iData’s analysts predict that the market will reach $2.9 billion. Similarly, the cardiac ablation catheter market is growing and is approaching $3.4 billion by 2025.  What Segments does iData

iData’s report on the global peripheral vascular stents market covers bare-metal stents (BMS), covered stents, and drug-eluting stents (DES). In 2018, the drug-eluting stent market suffered extreme consequences after studies demonstrating the late-mortality signal from paclitaxel use within the peripheries were released. Although the FDA released a statement approving the use of paclitaxel devices, many

Canada’s vascular access market includes medical devices with the ability to access a patient’s veins and arteries as well as accessories to improve safety and performance. By 2026, Canada’s vascular access market expects to reach $352.5 million at a CAGR of 2%. Overall, there are many vascular access devices, and iData’s analysis includes a wide

The global coronary balloon catheters market size should keep a positive trajectory, reaching $3.5 billion by 2027, with the drug-eluting market segment representing the majority of the total market. Currently, Boston Scientific, Medtronic, and Philips control the global market share.  What is the global market landscape for coronary balloon catheters? The first devices used in

Overall, the global transcatheter mitral valve repair device market was valued at $763.6 million in 2020, which is a 2.2% increase from $747 million in 2019. This is expected to increase over the forecast period at a CAGR of 16.4% to reach $2.2 billion. What do transcatheter mitral valve repair devices treat? The human heart

The total coronary stent market comprises bare-metal stents, drug-eluting stents, covered stents, and bifurcated stents. Stents can be defined as small mesh tubes inserted into an artery to prevent it from collapsing and keep it open after an angioplasty surgery (percutaneous coronary intervention, or PCI). Following multiple clinical studies that presented evidence of over-stenting in

Market trends for both the global Ventricular Assist Device (VAD) and Intra-aortic Balloon Pump (IABP) markets indicate growth over the forecast period and into 2027. Overall, the global VAD and IABP markets had a combined valuation of approximately $2 billion in 2020. These markets expect to reach a combined value of about $3.2 billion by

Overview Technology, especially when it comes to medical devices, is consistently advancing. As a result, it can be challenging to stay on top of the new procedures, devices, and advancements. If you have ever wanted to learn more about mechanical heart valves, the current and projected growth within this market, and how long they last,

Receive a free Interventional Cardiology Devices Market Report Suite for U.S.  synopsis and brochure iData Research, a leading international market research and consulting firm, has published results from their latest cardiovascular research revealing that there are over 2 million stents implanted per year in the United States. Approximately 1.2 Million of these can be attributed

  Intravascular ultrasound (IVUS) is an imaging technique that can be used as an alternative in peripheral procedures. IVUS provides the physician with a cross-sectional image of the vessel. Specifically, the technique is used in endovascular aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), carotid, subclavian, mesenteric, renal, iliac, superficial femoral artery (SFA), popliteal, inferior

Over the past few years, the peripheral vascular device market has seen substantial growth. Driven by forward-pressing research, increased awareness about treatment options, and an aging population in the United States, the total number of procedures performed and, therefore, the total number of devices used, has seen a strong and steady increase. One main disease

Keeping up with the market is hard enough without a looming global pandemic swinging it out of control. Although it is difficult to stay on top of recent trends, it is essential if you want to stay ahead of the market and your competition. Continually tracking trends, identifying who is doing well and why, along

Boston Scientific has announced they entered a definitive agreement to acquire Preventice Solutions Inc., a privately-held company that offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors to cardiac event monitors and mobile cardiac telemetry. The transaction will include an upfront cash payment of $925 million, and up

According to a new cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States. The US Cardiac surgery market is growing rapidly driven by the growth of many underlying procedures. The number of cardiac surgery procedures commonly includes: • Coronary Artery Bypass Grafting (CABG)•

According to a new atherectomy market study by iData Research, over 190,000 atherectomy procedures are performed each year in the United States. Atherectomy is a procedure that consists of removing atherosclerotic plaque from diseased arteries and can be performed either on coronary or peripheral arteries. Atherectomy devices are used as the treatment of choice, as

Based on the latest market analysis by iData Research, the European Transcatheter Aortic Valve Replacement (also known as TAVR/TAVI) market was valued at €836.2 million in 2020, which is a 29% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace the diseased aortic valve in patients with severe aortic stenosis. 

Medtronic has released its first-ever app-connected pacemaker called Azure. A pacemaker is an implantable device designed to regulate the electrical impulses of the heart. They are used to correct uneven heartbeats. Millions of patients have pacemaker implants to treat arrhythmia or heart failure. However, many patients do not understand how these devices function. This smartphone-connected

According to the latest Cardiac Surgery market study by iData Research, over 182,000 heart valve replacements are performed every year in the United States. These replacements are one of the most common procedures performed in the cardiac surgery market, and they make up nearly a quarter of the total procedure volume. Commonly, these procedures include

As we progress through the global pandemic and drive closer to having a vaccine available, companies are now preparing supplies such as needles and syringes. We have compiled the top three companies to watch as distributors for needles and syringes in the United States. Becton Dickinson  Cardinal Health Novo Nordisk Becton Dickinson Becton Dickinson produces

Register to receive a free TAVR Market Report Suite for the US 2020-2026 synopsis Based on the latest market analysis by iData Research, the Transcatheter Aortic Valve Replacement (TAVR) market was valued at $2,424 million in 2020, which is a 13% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace

Based on the latest market study by iData Research, the US infusion pump market was valued at almost $1,176 million in 2019. However, due to COVID, the market size is expected to shrink by an astonishing 51% and reach a valuation of $572 million in 2020, before rebounding in 2021. The infusion pump market is

Interventional cardiology is primarily applied to the treatment of coronary artery disease (CAD, also known as coronary heart disease), which is a specific cardiovascular illness. CAD encompasses myocardial infarction (MI) and angina pectoris, diseases that account for over half of all CAD cases. One of the most commonly performed surgical procedures used to treat CAD

Teleflex has announced its receival of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for the use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device is used to provide procedural guidance within the establishment of intraosseous vascular access, especially when intravenous access is difficult to obtain in

Interventional cardiology is a minimally-invasive technique that uses catheters to treat coronary arterial disease, which is one of the leading causes of death in the United States. These procedures allow the heart to continue functioning at its best moving almost 3,000 gallons of blood every day. Based on the European Heart Journal, cardiovascular disease (CVD)

The FDA Breakthrough Devices Program enables manufacturers to streamline the market clearance/approval process for specific medical devices. Medtronic received the breakthrough device designation for its investigational Intrepid™ transcatheter tricuspid valve replacement (TTVR) system. The FDA has also approved an early feasibility study for the device. The new TTVR system will help treat tricuspid valve regurgitation,